Yüklüyor......
Siplizumab selectively depletes effector memory T-cells and promotes a relative expansion of alloreactive regulatory T-cells in vitro
Siplizumab, a humanized anti-CD2 monoclonal antibody, has been used in conditioning regimens for hematopoietic cell transplantation and tolerance induction with combined kidney-bone marrow transplantation. Siplizumab-based tolerance induction regimens deplete T cells globally while enriching regulat...
Kaydedildi:
| Yayımlandı: | Am J Transplant |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6940533/ https://ncbi.nlm.nih.gov/pubmed/31319439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15533 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|